Clinical Trial Update: Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates a Phase 1/2 study of a novel oncolytic virus for recurrent malignant glioma (including glioblastoma) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• Novel Oncolytic Virus

Snippet

Sponsor: Beijing Neurosurgical Institute | Conditions: Glioblastoma Multiforme, Gliomas, Malignant | Phase 1, Phase 2 | Status: COMPLETED